-
Communities
-
Explore Vanderbilt communities
By latest
Featured community
Creative Data Solutions (CDS) is a Vanderbilt Shared Resource and has extensive experience in providing effective and robust solutions to challenges pertaining to research data using modern informatics and bioinformatics approaches.
-
- Resources
-
People
-
Publications
-
Explore publications
-
Keyword Connections
Connections to Immunoconjugates are shown below. Double-click or tap a node for more information.
Please note that publication matches are limited to 40 in this view. If you expected more, please view all publication matches for Immunoconjugates.
Members
- No matching connections
Resources
- No matching connections
Communities
- No matching connections
Publications
- Co-stimulation modulation with abatacept in patients with recent-onset type 1 diabetes: a randomised, double-blind, placebo-controlled trial.
Orban T, Bundy B, Becker DJ, DiMeglio LA, Gitelman SE, Goland R, Gottlieb PA, Greenbaum CJ, Marks JB, Monzavi R, Moran A, Raskin P, Rodriguez H, Russell WE, Schatz D, Wherrett D, Wilson DM, Krischer JP, Skyler JS, Type 1 Diabetes TrialNet Abatacept Study Group
(2011) Lancet 378: 412-9 - Inhibition and genetic ablation of the B7/CD28 T-cell costimulation axis prevents experimental hypertension.
Vinh A, Chen W, Blinder Y, Weiss D, Taylor WR, Goronzy JJ, Weyand CM, Harrison DG, Guzik TJ
(2010) Circulation 122: 2529-37 - A DLL3-targeted antibody-drug conjugate eradicates high-grade pulmonary neuroendocrine tumor-initiating cells in vivo.
Saunders LR, Bankovich AJ, Anderson WC, Aujay MA, Bheddah S, Black K, Desai R, Escarpe PA, Hampl J, Laysang A, Liu D, Lopez-Molina J, Milton M, Park A, Pysz MA, Shao H, Slingerland B, Torgov M, Williams SA, Foord O, Howard P, Jassem J, Badzio A, Czapiewski P, Harpole DH, Dowlati A, Massion PP, Travis WD, Pietanza MC, Poirier JT, Rudin CM, Stull RA, Dylla SJ
(2015) Sci Transl Med 7: 302ra136 - Costimulation modulation with abatacept in patients with recent-onset type 1 diabetes: follow-up 1 year after cessation of treatment.
Orban T, Bundy B, Becker DJ, Dimeglio LA, Gitelman SE, Goland R, Gottlieb PA, Greenbaum CJ, Marks JB, Monzavi R, Moran A, Peakman M, Raskin P, Russell WE, Schatz D, Wherrett DK, Wilson DM, Krischer JP, Skyler JS, Type 1 Diabetes TrialNet Abatacept Study Group
(2014) Diabetes Care 37: 1069-75 - CTLA-41g in combination with anti-CD40L prolongs xenograft survival and inhibits anti-gal ab production in GT-Ko mice.
Yin D, Ma L, Shen J, Byrne GW, Logan JS, Chong AS
(2002) Am J Transplant 2: 41-7 - Induction of tolerance to heart allografts in high responder rats by combining anti-CD4 with CTLA4Ig.
Yin D, Fathman CG
(1995) J Immunol 155: 1655-9 - Regulatory defects in Cbl and mitogen-activated protein kinase (extracellular signal-related kinase) pathways cause persistent hyperexpression of CD40 ligand in human lupus T cells.
Yi Y, McNerney M, Datta SK
(2000) J Immunol 165: 6627-34 - CTLA-4 engagement regulates NF-kappaB activation in vivo.
Harlin H, Hwang KW, Palucki DA, Kim O, Thompson CB, Boothby M, Alegre ML
(2002) Eur J Immunol 32: 2095-104 - The immunoconjugate "icon" targets aberrantly expressed endothelial tissue factor causing regression of endometriosis.
Krikun G, Hu Z, Osteen K, Bruner-Tran KL, Schatz F, Taylor HS, Toti P, Arcuri F, Konigsberg W, Garen A, Booth CJ, Lockwood CJ
(2010) Am J Pathol 176: 1050-6 - Induction of tolerance to small bowel allografts in high-responder rats by combining anti-CD4 with CTLA4Ig.
Yin DP, Sankary HN, Williams J, Krieger N, Fathman CG
(1996) Transplantation 62: 1537-9 - Effect of anti-CD4 monoclonal antibody combined with human CTLA4Ig on the survival of hamster liver and heart xenografts in Lewis rats.
Yin DP, Sankary HN, Chong AS, Blinder L, Ma LL, Williams JW
(1997) Transplantation 64: 317-21 - A chemically programmed antibody is a long-lasting and potent inhibitor of influenza neuraminidase.
Hayakawa M, Toda N, Carrillo N, Thornburg NJ, Crowe JE, Barbas CF
(2012) Chembiochem 13: 2191-5 - Immunotherapy and Targeted Therapy for Small Cell Lung Cancer: There Is Hope.
Lehman JM, Gwin ME, Massion PP
(2017) Curr Oncol Rep 19: 49 - CD40-ligand in primate cardiac allograft and viral immunity.
Pierson RN, Crowe JE, Pfeiffer S, Atkinson J, Azimzadeh A, Miller GG
(2001) Immunol Res 23: 253-62 - PEGylation strategies for active targeting of PLA/PLGA nanoparticles.
Betancourt T, Byrne JD, Sunaryo N, Crowder SW, Kadapakkam M, Patel S, Casciato S, Brannon-Peppas L
(2009) J Biomed Mater Res A 91: 263-76 - Radiation-mediated control of drug delivery.
Hallahan DE, Qu S, Geng L, Cmelak A, Chakravarthy A, Martin W, Scarfone C, Giorgio T
(2001) Am J Clin Oncol 24: 473-80 - Prolongation of cardiac graft survival with anti-CD4Ig plus hCTLA4Ig in primates.
Krieger NR, Yuh D, McIntyre WB, Flavin TF, Yin D, Robbins R, Fathman CG
(1998) J Surg Res 76: 174-8 - Efficacy of FK506, leflunomide, anti-CD4, and CTLA4IG treatments in rat to mouse pancreas xenograft transplantation.
Yin DP, Sankary HN, Shen J, Ma LL, Blinder L, Foster P, Williams JW, Chong A
(2000) Transplant Proc 32: 1003-4
Hints: (1) double-click or double-tap to navigate to a node. (2) Grab a node and move it to arrange the graph.
